BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'mara NB. Anemia in Patients With Chronic Kidney Disease. Diabetes Spectrum 2008;21:12-9. [DOI: 10.2337/diaspect.21.1.12] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Yee J, Zasuwa G, Frinak S, Besarab A. Hemoglobin Variability and Hyporesponsiveness: Much Ado About Something or Nothing? Advances in Chronic Kidney Disease 2009;16:83-93. [DOI: 10.1053/j.ackd.2008.12.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
2 Chuengsaman P, Narenpitak S, Sritippayawan S. Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis. World J Nephrol 2021; 10(6): 109-121 [PMID: 34909408 DOI: 10.5527/wjn.v10.i6.109] [Reference Citation Analysis]
3 Pramod S, Goldfarb DS. Challenging patient phenotypes in the management of anaemia of chronic kidney disease. Int J Clin Pract 2021;:e14681. [PMID: 34331826 DOI: 10.1111/ijcp.14681] [Reference Citation Analysis]
4 Alsalimy N, Awaisu A. Methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa for anemia in non-dialysis-dependent CKD: a systematic review. Int J Clin Pharm 2014;36:1115-25. [DOI: 10.1007/s11096-014-0023-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wittwer I. Iron deficiency anaemia in chronic kidney disease. J Ren Care 2013;39:182-8. [PMID: 23911105 DOI: 10.1111/j.1755-6686.2013.12026.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
6 Bennett L. PATIENT INDEPENDENCE IN CHRONIC KIDNEY DISEASE AND ANAEMIA: IMPLICATIONS OF THE 2012 KDIGO GUIDELINE: PATIENT INDEPENDENCE IN CKD AND ANAEMIA: IMPLICATIONS OF THE 2012 KDIGO GUIDELINE. Journal of Renal Care 2013;39:108-17. [DOI: 10.1111/j.1755-6686.2013.12010.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
7 Norton JM, Newman EP, Romancito G, Mahooty S, Kuracina T, Narva AS. CE: Improving Outcomes for Patients with Chronic Kidney Disease: Part 2. Am J Nurs 2017;117:26-35. [PMID: 28187016 DOI: 10.1097/01.NAJ.0000513259.90613.27] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
8 Escandell-Montero P, Chermisi M, Martínez-Martínez JM, Gómez-Sanchis J, Barbieri C, Soria-Olivas E, Mari F, Vila-Francés J, Stopper A, Gatti E, Martín-Guerrero JD. Optimization of anemia treatment in hemodialysis patients via reinforcement learning. Artif Intell Med 2014;62:47-60. [PMID: 25091172 DOI: 10.1016/j.artmed.2014.07.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
9 Azmi S, Goh A, Muhammad NA, Tohid H, Rashid MRA. The Cost and Quality of Life of Malaysian Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease and Anemia. Value Health Reg Issues 2018;15:42-9. [PMID: 29474177 DOI: 10.1016/j.vhri.2017.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]